Arbovirus Testing Market Size & Share | Trends Report, 2032

Arbovirus Testing Market Size - By Test Type (ELISA-based Tests, RT-PCR Based Tests), By End-use (Public Health Laboratory, Hospitals, Diagnostic Centers) – Global Forecast to 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definitions

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; working

1.2.1&nbsp;&nbsp;&nbsp; Data collection

1.3&nbsp;&nbsp;&nbsp; Forecast calculations

1.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Arbovirus testing industry 360&deg; synopsis, 2018 - 2032 (USD Million)

2.2&nbsp;&nbsp;&nbsp; Business trends

2.3&nbsp;&nbsp;&nbsp; Regional trends

2.4&nbsp;&nbsp;&nbsp; Test type trends

2.5&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Arbovirus Testing Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Rising prevalence rate of arthropod-borne viral diseases

3.2.1.2&nbsp;&nbsp;&nbsp;Technological advancements in testing products

3.2.1.3&nbsp;&nbsp;&nbsp;Availability of rapid serology tests in developed countries

3.2.1.4&nbsp;&nbsp;&nbsp;Increasing investment towards R&amp;D by biopharmaceutical companies

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Scarcity of in-vitro facilities

3.2.2.2&nbsp;&nbsp;&nbsp;Lack of awareness and limited availability of diagnostic testing procedures in some developing counties

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By test type

3.3.2&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Technology landscape

3.6&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6.1&nbsp;&nbsp;&nbsp; U.S.

3.6.2&nbsp;&nbsp;&nbsp; Europe

3.7&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive dashboard, 2022

4.4&nbsp;&nbsp;&nbsp; Company market share analysis, 2022

4.5&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.6&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.7&nbsp;&nbsp;&nbsp; Strategic outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Arbovirus Testing Market Size and Forecast, By Test Type (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by test type

5.2&nbsp;&nbsp;&nbsp; ELISA-based tests

5.3&nbsp;&nbsp;&nbsp; RT-PCR based tests

5.4&nbsp;&nbsp;&nbsp; Others

Chapter 6&nbsp;&nbsp;&nbsp;Arbovirus Testing Market Size and Forecast, By End-use (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by end-use

6.2&nbsp;&nbsp;&nbsp; Hospitals

6.3&nbsp;&nbsp;&nbsp; Diagnostic centers

6.4&nbsp;&nbsp;&nbsp; Public health laboratory

6.5&nbsp;&nbsp;&nbsp; Others

Chapter 7&nbsp;&nbsp;&nbsp;Arbovirus Testing Market Size and Forecast, By Region (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by region

7.2&nbsp;&nbsp;&nbsp; North America

7.2.1&nbsp;&nbsp;&nbsp; U.S.

7.2.2&nbsp;&nbsp;&nbsp; Canada

7.3&nbsp;&nbsp;&nbsp; Europe

7.3.1&nbsp;&nbsp;&nbsp; Germany

7.3.2&nbsp;&nbsp;&nbsp; UK

7.3.3&nbsp;&nbsp;&nbsp; France

7.3.4&nbsp;&nbsp;&nbsp; Spain

7.3.5&nbsp;&nbsp;&nbsp; Italy

7.3.6&nbsp;&nbsp;&nbsp; Belgium

7.3.7&nbsp;&nbsp;&nbsp; The Netherlands

7.3.8&nbsp;&nbsp;&nbsp; Switzerland

7.3.9&nbsp;&nbsp;&nbsp; Poland

7.3.10&nbsp;&nbsp;&nbsp; Sweden

7.4&nbsp;&nbsp;&nbsp; Asia Pacific

7.4.1&nbsp;&nbsp;&nbsp; China

7.4.2&nbsp;&nbsp;&nbsp; Japan

7.4.3&nbsp;&nbsp;&nbsp; India

7.4.4&nbsp;&nbsp;&nbsp; Australia

7.4.5&nbsp;&nbsp;&nbsp; South Korea

7.4.6&nbsp;&nbsp;&nbsp; New Zealand

7.4.7&nbsp;&nbsp;&nbsp; Thailand

7.4.8&nbsp;&nbsp;&nbsp; Singapore

7.4.9&nbsp;&nbsp;&nbsp; Vietnam

7.5&nbsp;&nbsp;&nbsp; Latin America

7.5.1&nbsp;&nbsp;&nbsp; Brazil

7.5.2&nbsp;&nbsp;&nbsp; Mexico

7.5.3&nbsp;&nbsp;&nbsp; Argentina

7.5.4&nbsp;&nbsp;&nbsp; Colombia

7.5.5&nbsp;&nbsp;&nbsp; Chile

7.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

7.6.1&nbsp;&nbsp;&nbsp; South Africa

7.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

7.6.3&nbsp;&nbsp;&nbsp; UAE

7.6.4&nbsp;&nbsp;&nbsp; Turkey

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; Agilent Technologies Inc.

8.2&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific

8.3&nbsp;&nbsp;&nbsp; NovaTec Immundiagnostica GmbH

8.4&nbsp;&nbsp;&nbsp; Euroimmun AG

8.5&nbsp;&nbsp;&nbsp; Abbott Laboratories

8.6&nbsp;&nbsp;&nbsp; DiaSorin SpA

8.7&nbsp;&nbsp;&nbsp; QIAGEN N.V.

8.8&nbsp;&nbsp;&nbsp; Fluke Biomedical

8.9&nbsp;&nbsp;&nbsp; Copley Scientific

8.10&nbsp;&nbsp;&nbsp; Distek

8.11&nbsp;&nbsp;&nbsp; Becton, Dickinson and Company

8.12&nbsp;&nbsp;&nbsp; Merck KGaA

8.13&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories

8.14&nbsp;&nbsp;&nbsp; F. Hoffmann La Roche Ltd.

8.15&nbsp;&nbsp;&nbsp; Siemens Healthineers AG 
&nbsp; &nbsp;

Arbovirus Testing Market

Get a free sample of this report